Free University of Brussels (ULB), PHARMED

Post-Graduate Programme in Pharmaceutical Medicine & Medicines Development Sciences

Practical Information

Commencing Date :
Language :
Location :
Brussels Belgium

Teaching Methodology :
Duration :
2 Year(s)

European Fees :
Scholarship Possibilities :

Course Contact

Jean-Marie Boeynaems


Office Link

Free University of Brussels (ULB), PHARMED

University Accreditation : Yes

Centre of Excellence


The PHARMED (now recognized as a PharmaTrain Centre of excellence) programme follows closely the training syllabus for pharmaceutical medicine issued by PharmaTrain. It is constituted by 16 modules of 2 days. With the assignments and homework, this represents 30 ECTS credits. Attendance of the modules can be completed over two years or more. Selective attendance of some modules is also feasible. All the courses are given in English on the Erasme Campus of the Université Libre de Bruxelles. The faculty is composed of experts from various universities, regulatory authorities and companies (biotech,CROs and big pharma). A "Diploma in Pharmaceutical Medicine" (DPM) is granted to physicians and a degree of "Diploma of University Professional in Pharmaceutical Medicine" is granted to non physicians who appear for the examination. (Note: This course can be upgraded to a Master by chosing modules from other PharmaTrain Centre of Excellence Universities. Please contact course contact for further information) A certificate of attendance is delivered to the participants who do not want to sit the examination.

Covered Areas

Scientific Areas

- PK/PD modelling - Production technologies - Target discovery and lead selection


- Quality : GMP, GCP, GLP

IMI Standards

  • A predefined set of teaching objectives, leading to defined learning outcomes
  • Assessment of the students' achievement in accordance with the agreed learning outcomes of the training offered
  • A system for collecting, assessing and addressing feedback from learners, teachers, technical / administrative staff and programme / course / module managers
  • Availability of appropriate and regularly reviewed reference material (e.g. published articles, links, book chapters, scripts, etc)
  • Defined and transparent admission criteria
  • Quality assurance of teaching staff
  • Regular review of the QA/QC process and demonstration that the training is further developed in light of this review
  • The facilities, infrastructure, leadership and competences available for the support of student learning
  • University accreditation OR a system for approving, monitoring and reviewing the training offered


Module Title





Introduction to Medicines Development 20-21 January 2016 2 Days No
Discovery of Medicines 24-25 February 2016 2 Days No
Preclinical Safety 23-24 March 2016 2 Days No
Drug Formulation and Manufacturing : 20-21 April 2016 2 Days No
Moving to Clinical Trials : Methodological and Ethical Aspects 25-26 May 2016 2 Days No
Clinical Trials Design and Protocol Writing 22-23 June 2016 2 Days No
Advanced Biostatistics 21-22 September 2016 2 Days No
Advanced Pharmacokinetics 26-27 October 2016 2 Days No
Conduct of Clinical Trials 25-26 January 2017 2 Days No
Clinical Trials Reporting and Auditing 22-23 February 2017 2 Days No
Pharmacovigilance 22-23 March 2017 2 Days No
Regulatory Affairs 26-27 April 2017 2 Days No
Medical Affairs 23-24 May 2017 2 Days No
Health Economic Analysis 21-22 June 2017 2 Days No
Marketing of Medicinal Products 27-28 September 2017 2 Days No
Specificities and Evolution of the Biopharmaceutical Market 25-26 October 2017 2 Days No